Physician

Ravindra Pawar, M.D.

According to 2025 Medicare claims, Ravindra Pawar, M.D. (NPI: 1598762155) practices nephrology in the Mansfield, OH market, with the plurality of this provider's patient population coming from Richland, OH. This provider's primary affiliated billing organization is KIDNEY ASSOCIATES, INC. (NPI: 1851348304; TIN: 341346017) and primary practice location at 44906-2969. Pawar is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Pawar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 234 traditional Medicare patients, billed 759 HCPCS/CPT codes, and received $129,538 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,977 prescription claims across 303 beneficiaries totaling $287,462 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). 2020 DME data shows 11 claims. Open Payments data shows 4 records totaling $6. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $321,750 to $129,538. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $484,881 to $287,462. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	707	2,844	$321,750
2016	756	3,267	$355,297
2017	717	2,898	$333,471
2018	581	2,587	$352,074
2019	503	2,325	$287,118
2020	505	2,404	$294,251
2021	322	1,278	$228,159
2022	316	1,011	$177,923
2023	250	840	$135,225
2024	234	759	$129,538

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	279	2,632	$484,881
2016	305	2,722	$907,099
2017	285	2,433	$648,228
2018	321	2,639	$265,357
2019	281	2,578	$267,296
2020	274	2,681	$284,275
2021	276	2,514	$240,208
2022	285	2,033	$164,057
2023	334	2,306	$298,356
2024	303	1,977	$287,462

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$1,409
2018	N/R	13	$245
2019	N/R	N/R	N/R
2020	N/R	11	$677
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	44	274	$268
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	12	14	$224
99495	Transitional care management services for problem of at least moderate complexity	17	22	$159
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	159	261	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	38	45	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	35	1,110	$97,734
Entresto	Sacubitril/Valsartan	47	1,713	$38,027
Farxiga	Dapagliflozin Propanediol	31	1,470	$25,656
Auryxia	Ferric Citrate	18	540	$22,769
Sevelamer Carbonate	Sevelamer Carbonate	193	7,740	$16,512

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$6	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ravindra Pawar, M.D.?

Tedicare shows public-source Medicare data for Ravindra Pawar, M.D. (NPI 1598762155), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ravindra Pawar, M.D. have ACO affiliation data?

Ravindra Pawar, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Ravindra Pawar, M.D.?

Ravindra Pawar, M.D. is linked to KIDNEY ASSOCIATES, INC. (billing NPI 1851348304) in the available physician profile data.

Does Ravindra Pawar, M.D. have Open Payments data?

Ravindra Pawar, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.